Increasing uptake of Gardasil among American adolescents: comparisons with the history of Hepatitis B vaccination. Academic Article

abstract

• OBJECTIVES: This paper identifies differences in the uptake rate of Gardasil and contrasts Gardasil uptake rate with the history of Hepatitis B vaccination. METHODS: A targeted review of peer-reviewed journals and industry commentary was conducted. New trends were calculated and figures created based on secondary data. RESULTS: The distribution of HPV vaccine does not conform to the geographic incidence rate of cervical cancer. Contrary to contemporary belief, school immunization mandates for Hepatitis B vaccines were not the impetus for their acceptance. Familial beliefs about HPV vaccines appear to be the most significant challenge to Gardasil uptake rate. CONCLUSIONS: Gardasil is at a critical juncture for increased uptake. Evidence-based educational interventions are needed.

authors

• Ory, Marcia
• Smith, Matthew

published proceedings

• Hum Vaccin

author list (cited authors)

• Dickerson, J. B., Smith, M. L., & Ory, M. G.

citation count

• 9

complete list of authors

• Dickerson, Justin B||Smith, Matthew Lee||Ory, Marcia G

publication date

• February 2011

publisher

• Taylor & Francis  Publisher

published in

• Human Vaccines and Immunotherapeutics  Journal

keywords

• Adolescent
• Child, Preschool
• Costs And Cost Analysis
• Hepatitis B Vaccines
• Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
• Humans
• Infant
• Infant, Newborn
• Papillomavirus Vaccines
• United States
• Vaccination

PubMed Central ID

• 21311218

Digital Object Identifier (DOI)

• 10.4161/hv.7.2.13633

start page

• 211

end page

• 219

volume

• 7

issue

• 2

URL

• http://dx.doi.org/10.4161/hv.7.2.13633

user-defined tag

• 3 Good Health and Well-Being